Corticosteroids in the management of bowel obstruction on a gynecological oncology unit

Gynecologic Oncology

Volumn 74, Issue 1, 1999, Pages 68-73

  Philip, J ^a   Lickiss, N ^a   Grant, P T ^a   Hacker, N F ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Bowel obstruction; Corticosteroids; Gynecologic cancer

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; GYNECOLOGIC CANCER; HUMAN; INTESTINE OBSTRUCTION; PALLIATIVE THERAPY; PRIORITY JOURNAL;

EID: 0032799320     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5406     Document Type: Article

References (30)

1. Trunca J C, Buchler D A, Mack E A, Ruzicka F F, Crowley J J, Corr W F. The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol. 12:1981;186-192.
2. Walsh H, Schofield P. Is laparotomy for small bowel obstruction justified in patients with previously treated malignancy. Br J Surg. 71:1984;933-935.
3. Solomon H J, Atkinson K H, Coppleson V M, Elliot P M, Houghton C R, Tattersall M H, Green D. Bowel complications in the management of ovarian cancer. Aust NZ Obstet Gynaecol. 23:1983;65-68.
4. Beattie G, Leonard R, Smyth J. Bowel obstruction in ovarian carcinoma: a retrospective study and review of the literature. Pall Med. 3:1989;275-280.
5. Hogan W M, Boente M P. The role of surgery in the management of recurrent gynecologic cancer. Semin Oncol. 20:1993;462-472.
6. Krebs H, Goplerud D. Mechanical intestinal obstruction in patients with gynecologic disease: a review of 368 patients. Am J Obstet Gynecol. 157:1987;577-583.
7. Lund B, Hansen M, Lundvall F, Nielsen N, Sorensen B, Hansen H. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet. 169:1989;213-218.
8. Piver M S, Barlow J, Lele S B. Survival after ovarian cancer induced intestinal obstruction. Gynecol Oncol. 13:1982;44-49.
9. Ripamonte C. Malignant bowel obstruction in advanced and terminal cancer patients. Eur J Pall Care. 1:1994;16-19.
10. Baines M, Oliver D, Carter R. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet. 2:1985;990-993.
11. Mercadante S, Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage. 7:1992;496-498.
12. Stiefel F, Morant R. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer. Supp Care Cancer. 1:1993;57-58.
13. Malone J, Koonce T, Larson D, Carrasco C, Saul P. Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol. 68:1986;431.
14. Farr W C. The use of corticosteroids for symptom management in terminally ill patients. Am J Hospice Care. 1:1990;41-46.
15. Ripamonte C. Management of bowel obstruction in advanced cancer patients. J Pain Symptom Manage. 9:1994;193-200.
16. Fainsinger R, Spachynski K, Hanson J, Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage. 9:1994;12-18.
17. Weissman D. Glucocorticoid treatment for brain metastases and epidural spinal cord compresssion. a review. J Clin Oncol. 6:1988;543-551.
18. Hanks G, Trueman T, Twycross R. Corticosteroids in terminal cancer - a prospective analysis of current practice. Postgrad Med J. 59:1983;702-706.
19. Chye R, Lickiss N. The use of corticosteroids in the management of bilateral malignant ureteric obstruction. J Pain Symptom Manage. 9:1994;537-540.
20. Krebs H, Goplerud D. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol. 61:1983;327-330.
21. MacDonald N. Principles Governing the Use of Cancer Chemotherapy in Palliative Medicine. Doyle D, Hanks G, MacDonald N. Oxford Textbook of Palliative Medicine. 1993;106 Oxford Univ. Press, Oxford.
22. Needham P, Daley A, Lennard R. Steroids in advanced cancer: a survey of current practice. Br Med J. 305:1992;999.
23. Kirwan J. Systemic Corticosteroids in Rheumatology. Klippel J, Dieppe P. Rheumatology. 1998;Mosby, London.
24. Schell H. The risk of adrenal corticosteroid therapy in far advanced cancer. Am J Med Sci. 252:1966;641.
25. Schell H. Adrenal corticosteroid therapy in far-advanced cancer. Geriatrics. 27:1972;131.
26. Messer J, Reitman D, Sacks H S, Smith H, Chalmers T C. Association of adrenocorticosteroid therapy and peptic ulcer disease. N Engl J Med. 309:1983;21-24.
27. Martindale, The Extra Pharmacopoeia, 31st ed, London, The Royal Pharmaceutical Society, 1996.
28. Twycross R. Corticosteroids in advanced cancer. Br Med J. 305:1992;969-970.
29. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep. 69:1985;751-754.
30. Hardy J, Ling J, Mansi J, Isaacs R. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Pall Med. 12:1998;437-442.